Acquisition of methicillin-resistant Staphylococcus aureus after living donor liver transplantation: a retrospective

Masao Hashimoto1, Yasuhiko Sugawara, Sumihito Tamura

  • 1Artificial Organ and Transplantation Division, Department of Surgery, University of Tokyo, Tokyo, Japan. hashimom-tky@umin.ac.jp

BMC Infectious Diseases
|November 19, 2008
PubMed
Abstract

Insights

Methicillin-resistant Staphylococcus aureus (MRSA) frequently occurs after adult living donor liver transplantation (LDLT). Older age and perioperative dialysis/apheresis increase MRSA risk, while fluoroquinolone use may decrease it.

Area of Science:

  • Hepatology
  • Infectious Diseases
  • Transplantation Medicine

Background:

  • The incidence and risk factors for methicillin-resistant Staphylococcus aureus (MRSA) acquisition post-living donor liver transplantation (LDLT) remain largely unknown.
  • Understanding these factors is crucial for preventing post-transplant infections.

Purpose of the Study:

  • To determine the incidence of MRSA acquisition in adult LDLT recipients.
  • To identify risk factors associated with MRSA acquisition after LDLT using multivariate analysis.

Main Methods:

  • Retrospective review of 158 adult patients undergoing LDLT.
  • Analysis of microbiologic and medical records from admission to 3 months post-LDLT.
  • Uni- and multivariate analyses to identify risk factors for MRSA acquisition.

Main Results:

  • MRSA was acquired by 35 out of 158 patients, with a median detection on postoperative day 18.
  • Advanced age (≥60 years) and perioperative dialysis/apheresis were significant predictors of MRSA acquisition.
  • Postoperative fluoroquinolone use showed a negative association with MRSA acquisition.

Conclusions:

  • MRSA incidence is high and occurs early after adult LDLT.
  • Periodic surveillance cultures are recommended post-LDLT to detect and prevent MRSA transmission.

Related Concept Videos

Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living donor...
Tissue Transplantation01:24

Tissue Transplantation

Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...